Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 3 November 1995:
Vol. 270. no. 5237, pp. 797 - 800
DOI: 10.1126/science.270.5237.797
Prev | Table of Contents | Next

Reports

Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development

Sarah M. Russell,  Nahid Tayebi (1),  Hiroshi Nakajima (1),  Mary C. Riedy (2),  Joseph L. Roberts (2),  M. Javad Aman (2),  Thi-Sau Migone,  Masayuki Noguchi,  M. Louise Markert,  Rebecca H. Buckley,  John J. O'Shea,  Warren J. Leonard (3)

Males with X-linked severe combined immunodeficiency (XSCID) have defects in the common cytokine receptor chain ((c)) gene that encodes a shared, essential component of the receptors for interleukin-2 (IL-2), IL-4, IL-7, IL-9, and IL-15. The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with (c), so it was hypothesized that defects in Jak3 might cause an XSCID-like phenotype. A girl with immunological features indistinguishable from those of XSCID was therefore selected for analysis. An Epstein-Barr virus (EBV)-transformed cell line derived from her lymphocytes had normal (c) expression but lacked Jak3 protein and had greatly diminished Jak3 messenger RNA. Sequencing revealed a different mutation on each allele: a single nucleotide insertion resulting in a frame shift and premature termination in the Jak3 JH4 domain and a nonsense mutation in the Jak3 JH2 domain. The lack of Jak3 expression correlated with impaired B cell signaling, as demonstrated by the inability of IL-4 to activate Stat6 in the EBV-transformed cell line from the patient. These observations indicate that the functions of (c) are dependent on Jak3 and that Jak3 is essential for lymphoid development and signaling.


S. M. Russell, H. Nakajima, M. J. Aman, T.-S. Migone, M. Noguchi, W. J. Leonard, Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
N. Tayebi, Unit on Clinical Genetics, Clinical Neuroscience Branch, National Institute of Mental Health, NIH, Bethesda, MD 20892, USA.
M. C. Riedy and J. J. O'Shea, Arthritis and Rheumatism Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD 20892, USA.
J. L. Roberts, Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA.
M. L. Markert and R. H. Buckley, Departments of Immunology and Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA.
(1) These authors contributed equally to this work.
(2) These authors contributed equally to this work.
(3) To whom correspondence should be addressed at Laboratory of Molecular Immunology, NHLBI, NIH, Building 10, Room 7N244, Bethesda, MD 20892-1674, USA.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A Novel Indole-3-propanamide Exerts Its Immunosuppressive Activity by Inhibiting JAK3 in T Cells.
D. Carbonnelle, M. Duflos, P. Marchand, C. Chauvet, J.-Y. Petit, and F. Lang (2009)
J. Pharmacol. Exp. Ther. 331, 710-716
   Abstract »    Full Text »    PDF »
TSLP and IL-7 use two different mechanisms to regulate human CD4+ T cell homeostasis.
N. Lu, Y.-H. Wang, Y.-H. Wang, K. Arima, S. Hanabuchi, and Y.-J. Liu (2009)
J. Exp. Med. 206, 2111-2119
   Abstract »    Full Text »    PDF »
IL-21 Contributes to JAK3/STAT3 Activation and Promotes Cell Growth in ALK-Positive Anaplastic Large Cell Lymphoma.
J. Dien Bard, P. Gelebart, M. Anand, Z. Zak, S. A. Hegazy, H. M. Amin, and R. Lai (2009)
Am. J. Pathol. 175, 825-834
   Abstract »    Full Text »    PDF »
Effect of CP-690,550, an Orally Active Janus Kinase Inhibitor, on Renal Function in Healthy Adult Volunteers.
N. Lawendy, S. Krishnaswami, R. Wang, D. Gruben, C. Cannon, S. Swan, and G. Chan (2009)
J. Clin. Pharmacol. 49, 423-429
   Abstract »    Full Text »    PDF »
Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models.
M. G. Cornejo, M. G. Kharas, M. B. Werneck, S. L. Bras, S. A. Moore, B. Ball, M. Beylot-Barry, S. J. Rodig, J. C. Aster, B. H. Lee, et al. (2009)
Blood 113, 2746-2754
   Abstract »    Full Text »    PDF »
Myeloproliferative disorders.
R. L. Levine and D. G. Gilliland (2008)
Blood 112, 2190-2198
   Abstract »    Full Text »    PDF »
IL-7 Activates the Phosphatidylinositol 3-Kinase/AKT Pathway in Normal Human Thymocytes but Not Normal Human B Cell Precursors.
S. E. Johnson, N. Shah, A. A. Bajer, and T. W. LeBien (2008)
J. Immunol. 180, 8109-8117
   Abstract »    Full Text »    PDF »
Phosphorylation of Human Jak3 at Tyrosines 904 and 939 Positively Regulates Its Activity.
H. Cheng, J. A. Ross, J. A. Frost, and R. A. Kirken (2008)
Mol. Cell. Biol. 28, 2271-2282
   Abstract »    Full Text »    PDF »
Direct interaction between Kit and the interleukin-7 receptor.
T. Jahn, S. Sindhu, S. Gooch, P. Seipel, P. Lavori, E. Leifheit, and K. Weinberg (2007)
Blood 110, 1840-1847
   Abstract »    Full Text »    PDF »
Nonredundant roles for Stat5a/b in directly regulating Foxp3.
Z. Yao, Y. Kanno, M. Kerenyi, G. Stephens, L. Durant, W. T. Watford, A. Laurence, G. W. Robinson, E. M. Shevach, R. Moriggl, et al. (2007)
Blood 109, 4368-4375
   Abstract »    Full Text »    PDF »
T-B+NK+ severe combined immunodeficiency caused by complete deficiency of the CD3{zeta} subunit of the T-cell antigen receptor complex.
J. L. Roberts, J. P. H. Lauritsen, M. Cooney, R. E. Parrott, E. O. Sajaroff, C. M. Win, M. D. Keller, J. H. Carpenter, J. Carabana, M. S. Krangel, et al. (2007)
Blood 109, 3198-3206
   Abstract »    Full Text »    PDF »
Stat5a/b are essential for normal lymphoid development and differentiation.
Z. Yao, Y. Cui, W. T. Watford, J. H. Bream, K. Yamaoka, B. D. Hissong, D. Li, S. K. Durum, Q. Jiang, A. Bhandoola, et al. (2006)
PNAS 103, 1000-1005
   Abstract »    Full Text »    PDF »
Murine and Human IL-7 Activate STAT5 and Induce Proliferation of Normal Human Pro-B Cells.
S. E. Johnson, N. Shah, A. Panoskaltsis-Mortari, and T. W. LeBien (2005)
J. Immunol. 175, 7325-7331
   Abstract »    Full Text »    PDF »
Jak3 negatively regulates dendritic-cell cytokine production and survival.
K. Yamaoka, B. Min, Y.-J. Zhou, W. E. Paul, and J. J. O'Shea (2005)
Blood 106, 3227-3233
   Abstract »    Full Text »    PDF »
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders.
A. V. Jones, S. Kreil, K. Zoi, K. Waghorn, C. Curtis, L. Zhang, J. Score, R. Seear, A. J. Chase, F. H. Grand, et al. (2005)
Blood 106, 2162-2168
   Abstract »    Full Text »    PDF »
CXCL12 Signaling Is Independent of Jak2 and Jak3.
M. Moriguchi, B. D. Hissong, M. Gadina, K. Yamaoka, H. L. Tiffany, P. M. Murphy, F. Candotti, and J. J. O'Shea (2005)
J. Biol. Chem. 280, 17408-17414
   Abstract »    Full Text »    PDF »
The JAK3 inhibitor CP-690550 selectively reduces NK and CD8+ cell numbers in cynomolgus monkey blood following chronic oral dosing.
M. Conklyn, C. Andresen, P. Changelian, and E. Kudlacz (2004)
J. Leukoc. Biol. 76, 1248-1255
   Abstract »    Full Text »    PDF »
Janus Kinase (Jak) Subcellular Localization Revisited: THE EXCLUSIVE MEMBRANE LOCALIZATION OF ENDOGENOUS JANUS KINASE 1 BY CYTOKINE RECEPTOR INTERACTION UNCOVERS THE Jak{middle dot}RECEPTOR COMPLEX TO BE EQUIVALENT TO A RECEPTOR TYROSINE KINASE.
I. Behrmann, T. Smyczek, P. C. Heinrich, H. Schmitz-Van de Leur, W. Komyod, B. Giese, G. Muller-Newen, S. Haan, and C. Haan (2004)
J. Biol. Chem. 279, 35486-35493
   Abstract »    Full Text »    PDF »
Distinct Regions of the Interleukin-7 Receptor Regulate Different Bcl2 Family Members.
Q. Jiang, W. Q. Li, R. R. Hofmeister, H. A. Young, D. R. Hodge, J. R. Keller, A. R. Khaled, and S. K. Durum (2004)
Mol. Cell. Biol. 24, 6501-6513
   Abstract »    Full Text »    PDF »
Jak3-Independent Trafficking of the Common {gamma} Chain Receptor Subunit: Chaperone Function of Jaks Revisited.
S. R. Hofmann, A. Q. Lam, S. Frank, Y.-J. Zhou, H. L. Ramos, Y. Kanno, D. Agnello, R. J. Youle, and J. J. O'Shea (2004)
Mol. Cell. Biol. 24, 5039-5049
   Abstract »    Full Text »    PDF »
Mechanisms associated with IL-6-induced up-regulation of Jak3 and its role in monocytic differentiation.
J. K. Mangan, S. G. Rane, A. D. Kang, A. Amanullah, B. C. Wong, and E. P. Reddy (2004)
Blood 103, 4093-4101
   Abstract »    Full Text »    PDF »
The Molecular Pathology of Primary Immunodeficiencies.
M. S. Lim and K. S.J. Elenitoba-Johnson (2004)
J. Mol. Diagn. 6, 59-83
   Full Text »    PDF »
Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.
J. L. Roberts, A. Lengi, S. M. Brown, M. Chen, Y.-J. Zhou, J. J. O'Shea, and R. H. Buckley (2004)
Blood 103, 2009-2018
   Abstract »    Full Text »    PDF »
Effect of CD3{delta} Deficiency on Maturation of {alpha}/{beta} and {gamma}/{delta} T-Cell Lineages in Severe Combined Immunodeficiency.
H. K. Dadi, A. J. Simon, and C. M. Roifman (2003)
N. Engl. J. Med. 349, 1821-1828
   Full Text »    PDF »
A Sensitized Genetic Screen to Identify Novel Regulators and Components of the Drosophila Janus Kinase/Signal Transducer and Activator of Transcription Pathway.
E. A. Bach, S. Vincent, M. P. Zeidler, and N. Perrimon (2003)
Genetics 165, 1149-1166
   Abstract »    Full Text »    PDF »
Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor.
P. S. Changelian, M. E. Flanagan, D. J. Ball, C. R. Kent, K. S. Magnuson, W. H. Martin, B. J. Rizzuti, P. S. Sawyer, B. D. Perry, W. H. Brissette, et al. (2003)
Science 302, 875-878
   Abstract »    Full Text »    PDF »
Anti-apoptotic Signaling by the Interleukin-2 Receptor Reveals a Function for Cytoplasmic Tyrosine Residues within the Common gamma (gamma c) Receptor Subunit.
M. J. Lindemann, M. Benczik, and S. L. Gaffen (2003)
J. Biol. Chem. 278, 10239-10249
   Abstract »    Full Text »    PDF »
T Cell Repertoire Development in Humans with SCID After Nonablative Allogeneic Marrow Transplantation.
M. Sarzotti, D. D. Patel, X. Li, D. A. Ozaki, S. Cao, S. Langdon, R. E. Parrott, K. Coyne, and R. H. Buckley (2003)
J. Immunol. 170, 2711-2718
   Abstract »    Full Text »    PDF »
Immunodeficiency Disorders.
M. D. Cooper, L. L. Lanier, M. E. Conley, and J. M. Puck (2003)
Hematology 2003, 314-330
   Abstract »    Full Text »    PDF »
The Pseudokinase Domain Is Required for Suppression of Basal Activity of Jak2 and Jak3 Tyrosine Kinases and for Cytokine-inducible Activation of Signal Transduction.
P. Saharinen and O. Silvennoinen (2002)
J. Biol. Chem. 277, 47954-47963
   Abstract »    Full Text »    PDF »
Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
Z. S. Nagy, Y. Wang, R. A. Erwin-Cohen, J. Aradi, B. Monia, L. H. Wang, S. M. Stepkowski, H. Rui, and R. A. Kirken (2002)
J. Leukoc. Biol. 72, 819-828
   Abstract »    Full Text »    PDF »
Partial restoration of B cell development in Jak-3-/- mice achieved by co-expression of IgH and E{micro}-myc transgenes.
S. R. Dillon and M. S. Schlissel (2002)
Int. Immunol. 14, 893-904
   Abstract »    Full Text »    PDF »
Two Distinct Domains Within the N-Terminal Region of Janus Kinase 1 Interact with Cytokine Receptors.
A. Usacheva, S. Kotenko, M. M. Witte, and O. R. Colamonici (2002)
J. Immunol. 169, 1302-1308
   Abstract »    Full Text »    PDF »
Interleukin-7: from bench to clinic.
T. J. Fry and C. L. Mackall (2002)
Blood 99, 3892-3904
   Full Text »    PDF »
Successful Gene Therapy for Severe Combined Immunodeficiency.
F. S. Rosen (2002)
N. Engl. J. Med. 346, 1241-1243
   Full Text »    PDF »
Positive Effects of Glucocorticoids on T Cell Function by Up-Regulation of IL-7 Receptor {alpha}.
D. Franchimont, J. Galon, M. S. Vacchio, S. Fan, R. Visconti, D. M. Frucht, V. Geenen, G. P. Chrousos, J. D. Ashwell, and J. J. O'Shea (2002)
J. Immunol. 168, 2212-2218
   Abstract »    Full Text »    PDF »
Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival.
L. A. Myers, D. D. Patel, J. M. Puck, and R. H. Buckley (2002)
Blood 99, 872-878
   Abstract »    Full Text »    PDF »
Clonal Variation in the B-Lineage Acute Lymphoblastic Leukemia Response to Multiple Cytokines and Bone Marrow Stromal Cells.
N. Shah, L. Oseth, H. Tran, B. Hirsch, and T. W. LeBien (2001)
Cancer Res. 61, 5268-5274
   Abstract »    Full Text »    PDF »
Current topic: Severe combined immunodeficiency{---}molecular pathogenesis and diagnosis.
H B Gaspar, K C Gilmour, and A M Jones (2001)
Arch. Dis. Child. 84, 169-173
   Full Text »
Primary Immunodeficiency Diseases Due to Defects in Lymphocytes.
R. H. Buckley (2000)
N. Engl. J. Med. 343, 1313-1324
   Full Text »    PDF »
Jaks and Stats as therapeutic targets.
J. J O'Shea, R. Visconti, T. P Cheng, and M. Gadina (2000)
Ann Rheum Dis 59, i115-118
   Abstract »    Full Text »    PDF »
A partial deficiency of interleukin-7Ralpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency.
C. M. Roifman, J. Zhang, D. Chitayat, and N. Sharfe (2000)
Blood 96, 2803-2807
   Abstract »    Full Text »    PDF »
A Profound Deficiency in Thymic Progenitor Cells in Mice Lacking Jak3.
A. M. Baird, J. A. Lucas, and L. J. Berg (2000)
J. Immunol. 165, 3680-3688
   Abstract »    Full Text »    PDF »
Lack of Phosphotyrosine Phosphatase SHP-1 Expression in Malignant T-Cell Lymphoma Cells Results from Methylation of the SHP-1 Promoter.
Q. Zhang, P. N. Raghunath, E. Vonderheid, N. Odum, and M. A. Wasik (2000)
Am. J. Pathol. 157, 1137-1146
   Abstract »    Full Text »    PDF »
Role of common cytokine receptor gamma chain (gamma c)- and Jak3-dependent signaling in the proliferation and survival of murine mast cells.
K. Suzuki, H. Nakajima, N. Watanabe, S.-i. Kagami, A. Suto, Y. Saito, T. Saito, and I. Iwamoto (2000)
Blood 96, 2172-2180
   Abstract »    Full Text »    PDF »
Fates of human B-cell precursors.
T. W. LeBien (2000)
Blood 96, 9-23
   Abstract »    Full Text »    PDF »
Hierarchy of Protein Tyrosine Kinases in Interleukin-2 (IL-2) Signaling: Activation of Syk Depends on Jak3; However, Neither Syk nor Lck Is Required for IL-2-Mediated STAT Activation.
Y.-J. Zhou, K. S. Magnuson, T. P. Cheng, M. Gadina, D. M. Frucht, J. Galon, F. Candotti, R. L. Geahlen, P. S. Changelian, and J. J. O'Shea (2000)
Mol. Cell. Biol. 20, 4371-4380
   Abstract »    Full Text »
Stable and functional lymphoid reconstitution of common cytokine receptor gamma chain deficient mice by retroviral-mediated gene transfer.
C. Soudais, T. Shiho, L. I. Sharara, D. Guy-Grand, T. Taniguchi, A. Fischer, and J. P. Di Santo (2000)
Blood 95, 3071-3077
   Abstract »    Full Text »    PDF »
A Murine Leukemia Virus (MuLV) Long Terminal Repeat Derived from Rhesus Macaques in the Context of a Lentivirus Vector and MuLV gag Sequence Results in High-Level Gene Expression in Human T Lymphocytes.
S. K. P. Kung, D. S. An, and I. S. Y. Chen (2000)
J. Virol. 74, 3668-3681
   Abstract »    Full Text »
Complex Effects of Naturally Occurring Mutations in the JAK3 Pseudokinase Domain: Evidence for Interactions between the Kinase and Pseudokinase Domains.
M. Chen, A. Cheng, F. Candotti, Y.-J. Zhou, A. Hymel, A. Fasth, L. D. Notarangelo, and J. J. O'Shea (2000)
Mol. Cell. Biol. 20, 947-956
   Abstract »    Full Text »
Janus kinase 3 (Jak3) is essential for common cytokine receptor {gamma} chain ({gamma}c)-dependent signaling: comparative analysis of {gamma}c, Jak3, and {gamma}c and Jak3 double-deficient mice.
K. Suzuki, H. Nakajima, Y. Saito, T. Saito, W. J. Leonard, and I. Iwamoto (2000)
Int. Immunol. 12, 123-132
   Abstract »    Full Text »    PDF »
Immunogenetics: changing the face of immunodeficiency.
A. M Jones and H. B Gaspar (2000)
J. Clin. Pathol. 53, 60-65
   Full Text »    PDF »
The Jak-Stat pathway in normal and perturbed hematopoiesis.
A. C. Ward, I. Touw, and A. Yoshimura (2000)
Blood 95, 19-29
   Full Text »    PDF »
Restoration of Lymphoid Populations in a Murine Model of X-Linked Severe Combined Immunodeficiency by a Gene-Therapy Approach.
M. Lo, M. L. Bloom, K. Imada, M. Berg, J. M. Bollenbacher, E. T. Bloom, B. L. Kelsall, and W. J. Leonard (1999)
Blood 94, 3027-3036
   Abstract »    Full Text »    PDF »
Gene Duplication of Zebrafish JAK2 Homologs Is Accompanied by Divergent Embryonic Expression Patterns: Only jak2a Is Expressed During Erythropoiesis.
A. C. Oates, A. Brownlie, S. J. Pratt, D. V. Irvine, E. C. Liao, B. H. Paw, K. J. Dorian, S. L. Johnson, J. H. Postlethwait, L. I. Zon, et al. (1999)
Blood 94, 2622-2636
   Abstract »    Full Text »    PDF »
Long-Term Chimerism and B-Cell Function After Bone Marrow Transplantation in Patients With Severe Combined Immunodeficiency With B Cells: A Single-Center Study of 22 Patients.
E. Haddad, F. L. Deist, P. Aucouturier, M. Cavazzana-Calvo, S. Blanche, G. D. S. Basile, and A. Fischer (1999)
Blood 94, 2923-2930
   Abstract »    Full Text »    PDF »
Reconstitution of Early Lymphoid Proliferation and Immune Function in Jak3-Deficient Mice by Interleukin-3.
M. P. Brown, T. Nosaka, R. A. Tripp, J. Brooks, J. M.A. van Deursen, M. K. Brenner, P. C. Doherty, and J. N. Ihle (1999)
Blood 94, 1906-1914
   Abstract »    Full Text »    PDF »
IL-10 Transgenic Mice Present a Defect in T Cell Development Reminiscent to SCID Patients.
M. Rouleau, F. Cottrez, M. Bigler, S. Antonenko, J. M. Carballido, A. Zlotnik, M.-G. Roncarolo, and H. Groux (1999)
J. Immunol. 163, 1420-1427
   Abstract »    Full Text »    PDF »
Dysregulated Myelopoiesis in Mice Lacking Jak3.
W. J. Grossman, J. W. Verbsky, L. Yang, L. J. Berg, L. E. Fields, D. D. Chaplin, and L. Ratner (1999)
Blood 94, 932-939
   Abstract »    Full Text »    PDF »
Deficient Cellular Immunity--Finding and Fixing the Defects.
P. D. Greenberg and S. R. Riddell (1999)
Science 285, 546-551
   Abstract »    Full Text »
JAK3, STAT, and MAPK Signaling Pathways as Novel Molecular Targets for the Tyrphostin AG-490 Regulation of IL-2-Mediated T Cell Response.
L. H. Wang, R. A. Kirken, R. A. Erwin, C.-R. Yu, and W. L. Farrar (1999)
J. Immunol. 162, 3897-3904
   Abstract »    Full Text »    PDF »
Downregulation of JAK3 Protein Levels in T Lymphocytes by Prostaglandin E2 and Other Cyclic Adenosine Monophosphate-Elevating Agents: Impact on Interleukin-2 Receptor Signaling Pathway.
V. Kolenko, P. Rayman, B. Roy, M. K. Cathcart, J. O'Shea, R. Tubbs, L. Rybicki, R. Bukowski, and J. Finke (1999)
Blood 93, 2308-2318
   Abstract »    Full Text »    PDF »
Hematopoietic Stem-Cell Transplantation for the Treatment of Severe Combined Immunodeficiency.
R. H. Buckley, S. E. Schiff, R. I. Schiff, M. L. Markert, L. W. Williams, J. L. Roberts, L. A. Myers, and F. E. Ward (1999)
N. Engl. J. Med. 340, 508-516
   Abstract »    Full Text »    PDF »
Functional Role of Interleukin-4 (IL-4) and IL-7 in the Development of X-Linked Severe Combined Immunodeficiency.
S. Kumaki, N. Ishii, M. Minegishi, S. Tsuchiya, D. Cosman, K. Sugamura, and T. Konno (1999)
Blood 93, 607-612
   Abstract »    Full Text »    PDF »
Virus-specific immunity after gene therapy in a murine model of severe combined immunodeficiency.
K. D. Bunting, K. J. Flynn, J. M. Riberdy, P. C. Doherty, and B. P. Sorrentino (1999)
PNAS 96, 232-237
   Abstract »    Full Text »    PDF »
Signaling via the IL-2 and IL-7 Receptors from the Membrane to the Nucleus.
W.J. LEONARD, K. IMADA, H. NAKAJIMA, A. PUEL, E. SOLDAINI, and S. JOHN (1999)
Cold Spring Harb Symp Quant Biol 64, 417-424
   Abstract »    PDF »
Src-Related Protein Tyrosine Kinases in Hematopoiesis.
S. J. Corey and S. M. Anderson (1999)
Blood 93, 1-14
   Full Text »    PDF »
Development of a Model for Evaluating the Interaction Between Human Pre-B Acute Lymphoblastic Leukemic Cells and the Bone Marrow Stromal Cell Microenvironment.
N. Shah, L. Oseth, and T. W. LeBien (1998)
Blood 92, 3817-3828
   Abstract »    Full Text »    PDF »
Role of JAK3 in CD40-Mediated Signaling.
H. H. Jabara, R. H. Buckley, J. L. Roberts, G. Lefranc, J. Loiselet, G. Khalil, and R. S. Geha (1998)
Blood 92, 2435-2440
   Abstract »    Full Text »    PDF »
Cutting Edge: JAK3 Activation and Rescue of T Cells from HIV gp120-Induced Unresponsiveness.
N. Selliah and T. H. Finkel (1998)
J. Immunol. 160, 5697-5701
   Abstract »    Full Text »    PDF »
Case 18-1998- A 54-Day-Old Premature Girl with Respiratory Distress and Persistent Pulmonary Infiltrates.
F. S. Rosen and A. K. Bhan (1998)
N. Engl. J. Med. 338, 1752-1758
   Full Text »    PDF »
Delineation of the Regions of Interleukin-2 (IL-2) Receptor beta  Chain Important for Association of Jak1 and Jak3. Jak1-INDEPENDENT FUNCTIONAL RECRUITMENT OF Jak3 TO IL-2Rbeta.
M.-h. Zhu, J. A. Berry, S. M. Russell, and W. J. Leonard (1998)
J. Biol. Chem. 273, 10719-10725
   Abstract »    Full Text »    PDF »
Requirement for Jak3 in Mature T Cells: Its Role in Regulation of T Cell Homeostasis.
S. J. Sohn, K. A. Forbush, N. Nguyen, B. Witthuhn, T. Nosaka, J. N. Ihle, and R. M. Perlmutter (1998)
J. Immunol. 160, 2130-2138
   Abstract »    Full Text »    PDF »
Development of Autologous, Oligoclonal, Poorly Functioning T Lymphocytes in a Patient With Autosomal Recessive Severe Combined Immunodeficiency Caused by Defects of the Jak3 Tyrosine Kinase.
D. Brugnoni, L. D. Notarangelo, A. Sottini, P. Airo, M. Pennacchio, E. Mazzolari, S. Signorini, F. Candotti, A. Villa, P. Mella, et al. (1998)
Blood 91, 949-955
   Abstract »    Full Text »    PDF »
Primary Immunodeficiency Diseases.
J. M. Puck (1997)
JAMA 278, 1835-1841
   Abstract »    PDF »
Distinct tyrosine phosphorylation sites in JAK3 kinase domain positively and negatively regulate its enzymatic activity.
Y.-J. Zhou, E. P. Hanson, Y.-Q. Chen, K. Magnuson, M. Chen, P. G. Swann, R. L. Wange, P. S. Changelian, and J. J. O'Shea (1997)
PNAS 94, 13850-13855
   Abstract »    Full Text »    PDF »
Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins.
S. Takemoto, J. C. Mulloy, A. Cereseto, T.-S. Migone, B. K. R. Patel, M. Matsuoka, K. Yamaguchi, K. Takatsuki, S. Kamihira, J. D. White, et al. (1997)
PNAS 94, 13897-13902
   Abstract »    Full Text »    PDF »
Structural and Functional Basis for JAK3-Deficient Severe Combined Immunodeficiency.
F. Candotti, S. A. Oakes, J. A. Johnston, S. Giliani, R. F. Schumacher, P. Mella, M. Fiorini, A. G. Ugazio, R. Badolato, L. D. Notarangelo, et al. (1997)
Blood 90, 3996-4003
   Abstract »    Full Text »    PDF »
Impaired Generation of Bone Marrow B Lymphocytes in Mice Deficient in C/EBPbeta.
X. Chen, W. Liu, C. Ambrosino, M. R. Ruocco, V. Poli, L. Romani, I. Quinto, S. Barbieri, K. L. Holmes, S. Venuta, et al. (1997)
Blood 90, 156-164
   Abstract »    Full Text »    PDF »
The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma  chain and confers the ability to transmit interleukin 2-mediated signals.
M. Chen, A. Cheng, Y.-Q. Chen, A. Hymel, E. P. Hanson, L. Kimmel, Y. Minami, T. Taniguchi, P. S. Changelian, and J. J. O'Shea (1997)
PNAS 94, 6910-6915
   Abstract »    Full Text »    PDF »
Impairment of T Cell Development in {delta}EF1 Mutant Mice.
Y. Higashi, H. Moribe, T. Takagi, R. Sekido, K. Kawakami, H. Kikutani, and H. Kondoh (1997)
J. Exp. Med. 185, 1467-1480
   Abstract »    Full Text »    PDF »
Mutation Analysis of IL2RG in Human X-Linked Severe Combined Immunodeficiency.
J. M. Puck, A. E. Pepper, P. S. Henthorn, F. Candotti, J. Isakov, T. Whitwam, M. E. Conley, R. E. Fischer, H. M. Rosenblatt, T. N. Small, et al. (1997)
Blood 89, 1968-1977
   Abstract »    Full Text »    PDF »
Interleukin-4 Signaling in B Lymphocytes from Patients with X-linked Severe Combined Immunodeficiency.
N. Taylor, F. Candotti, S. Smith, S. A. Oakes, T. Jahn, J. Isakov, J. M. Puck, J. J. O'Shea, K. Weinberg, and J. A. Johnston (1997)
J. Biol. Chem. 272, 7314-7319
   Abstract »    Full Text »    PDF »
Requirement for an initial signal from the membrane-proximal region of the interleukin 2 receptor gamma c chain for Janus kinase activation leading to T cell proliferation.
B. H. Nelson, B. C. McIntosh, L. L. Rosencrans, and P. D. Greenberg (1997)
PNAS 94, 1878-1883
   Abstract »    Full Text »    PDF »
Peripheral Expression of Jak3 Is Required to Maintain T Lymphocyte Function.
D. C. Thomis and L. J. Berg (1997)
J. Exp. Med. 185, 197-206
   Abstract »    Full Text »    PDF »
RAG Mutations in Human B Cell-Negative SCID.
K. Schwarz, G. H. Gauss, L. Ludwig, U. Pannicke, Z. Li, D. Lindner, W. Friedrich, R. A. Seger, T. E. Hansen-Hagge, S. Desiderio, et al. (1996)
Science 274, 97-99
   Abstract »    Full Text »
Distinct Tyrosine Residues within the Interleukin-2 Receptor beta Chain Drive Signal Transduction Specificity, Redundancy, and Diversity.
S. L. Gaffen, S. Y. Lai, M. Ha, X. Liu, L. Hennighausen, W. C. Greene, and M. A. Goldsmith (1996)
J. Biol. Chem. 271, 21381-21390
   Abstract »    Full Text »    PDF »
Cloning of Human Stat5B.
J.-X. Lin, J. Mietz, W. S. Modi, S. John, and W. J. Leonard (1996)
J. Biol. Chem. 271, 10738-10744
   Abstract »    Full Text »    PDF »
Defects in B Lymphocyte Maturation and T Lymphocyte Activation in Mice Lacking Jak3.
D. C. Thomis, C. B. Gurniak, E. Tivol, A. H. Sharpe, and L. J. Berg (1995)
Science 270, 794-797
   Abstract »    PDF »
Defective Lymphoid Development in Mice Lacking Jak3.
T. Nosaka, J. M. A. van Deursen, R. A. Tripp, W. E. Thierfelder, B. A. Witthuhn, P. C. Doherty, A. P. McMickle, G. C. Grosveld, and J. N. Ihle (1995)
Science 270, 800-802
   Abstract »    PDF »
Cytokine-independent Jak3 Activation upon T Cell Receptor (TCR) Stimulation through Direct Association of Jak3 and the TCR Complex.
K. Tomita, K. Saijo, S. Yamasaki, T. Iida, F. Nakatsu, H. Arase, H. Ohno, T. Shirasawa, T. Kuriyama, J. J. O'Shea, et al. (2001)
J. Biol. Chem. 276, 25378-25385
   Abstract »    Full Text »    PDF »
Differential requirement of the cytoplasmic subregions of gamma c chain in T cell development and function.
S. Tsujino, J. P. Di Santo, A. Takaoka, T. L. McKernan, S. Noguchi, C. Taya, H. Yonekawa, T. Saito, T. Taniguchi, and H. Fujii (2000)
PNAS 97, 10514-10519
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)